Page 413 - Avian Virology: Current Research and Future Trends
P. 413

404  |  Index
          IFITM (interferon induced transmembrane proteins)  380–81  Inclusion body hepatitis/hydropericardium syndrome (IBH/HPS)  283,
          IFNAR1/IFNAR2  379–80, 382                              299, 304, 305, 307, 308
          IFNs and IFN signalling  293, 294, 304, 378, 379, 381–82  Infectious bronchitis (IB)  333, 377
          IFN type I  379–80                                    Infectious bronchitis virus (IBV)  133–78
             antiviral state in chickens and  381                  AI diagnosis and  21
             avian adenoviruses and  294, 302, 303, 304            AMPV compared to  124
             IAVs and  12–13, 18–19                                CAV co-infection with  272
             IBDV and  216–17, 218, 220, 222                       diagnosis  161–63
             IBV and  158                                             genotype identification  162–63
             ILTV and  330                                            serotype identification  162
             NDV and  60, 61, 68–69                                   virus isolation and identification  161–62
             PTX3 and  378                                         epizootiology  160–61
             TLRs and  378–79                                      evolution  154–55
          IFN type II  68–69, 302, 303, 304, 379, 380              genetics and reverse genetics  155–56
          IFN type III  379, 380                                   genome structure and organization  137–38
          IFNα  51, 158, 218, 237, 271, 302–3, 378–80, 381–82      geographic distribution of variants  160
          IFNβ  51, 152, 158, 216, 218–20, 271, 303, 379–80, 382   history  133–34
          IFNγ  379, 380                                           host cell effects  151–54
             AIV/IAVs and  13, 17, 18, 386, 387                       activation transcription factor6 151–52
             ALV and  237                                             apoptosis  152
             avian adenoviruses and  294, 302–3, 308                  autophagy  153
             CAV and  271, 274                                        ER stress and unfolded protein response  151
             IBDV and  221                                            IRE1 152
             IBV and  160                                             MAPK pathway  153–54
             ILTV and  331                                            PERK signalling pathway  151
             NDV and  62                                           immune responses  158–60
             NK cells and  382                                        adaptive immunity  158–59, 385, 386, 387
             Th1 cells and  384                                       cell-mediated immunity  159–60
          IFNλ  379, 380                                              cytokines  160
          IgA  385                                                    innate immunity  158, 377, 378, 379, 380, 382, 383
          Ig (immunoglobulin) isotypes  384–85                        local immunity  159
          IgM  384                                                 IRE1 152
          IgY  385                                                 morphology  136
          IL-1  271, 293                                           nomenclature  134–35, 164
          IL-1β  158, 221, 237, 331, 379, 383                         classification  134
          IL-2  17, 62, 216, 221, 223, 274                            phylogenetic tree  135
          IL-4  271, 384                                              taxonomy of Coronaviridae  134
          IL-5  384                                                non-structural and accessory proteins  143–46
          IL-6  68, 139, 154, 160, 221, 223, 237, 271, 379, 383       accessory genes  143
          IL-7  223                                                   non-structural proteins  144–46
          IL-8  139, 154, 160, 219, 237, 302–3, 330, 383           pathogenesis and clinical features
          IL-10  271, 302–3, 331, 382, 384                            tissue tropism  157–58
          IL-12  13, 17, 223, 271, 302, 382, 383                      virulence factors  156–57
          IL-13  271, 331, 382, 384                                pathogenesis and clinical features  156–58
          IL-17  384                                               prevention and control  163
          IL-18  223, 237, 293, 302, 337, 382                         exclusion and eradication  163
          IL-23  384                                                  vaccination  163 (See also under Vaccines and vaccination)
          IL-28/29  379                                            propagation  136–37, 163
          IL-28Rα  380                                                chicken kidney (CK) cell cultures  137
          ILT. See Infectious laryngotracheitis (ILT)                 embryonated eggs  136–37
          Iltovirus  317, 318, 320, 325                               other cultured cell lines  137
          ILTV. See Infectious laryngotracheitis virus (ILTV)         tracheal organ cultures (TOCs)  137
          Immediate early (IE) gene expression  346                structural proteins  138–43
          Immune complex vaccines  222, 223                           E protein  140–41
          Immune responses to virus infection. See Avian immune responses to virus   host proteins recruited to mature virions  143
           infection                                                  M protein  140
          Immunoglobulin (Ig) isotypes  384–85                        N protein  142–43
          Immunoreceptor tyrosine-based activation motifs (ITAMs)  382  S protein  138–39
          Immunoreceptor tyrosine-based inhibition motifs (ITIMs)  382  viral replication  146–51
          Immunosuppression                                           assembly and release  149–51
             avian adenoviruses and  301, 302, 304                    attachment and entry  146–47
             avian reoviruses and  179, 189, 195, 196, 197            cleavage site and size of non-structural proteins  148
             CAV and  191, 249, 271–72, 273–74                        discontinuous transcriptional model of RNA synthesis  150
             IBDV and  211, 212, 215, 216, 217, 221, 222              life cycle  147
             MDV and  345, 357                                        replicase gene and processing scheme of replicase protein
             REV and  191, 373                                         products  148
          Imperfect vaccine hypothesis  337                           replicase translation and processing  147–48
          Importin α/β transport pathway  12                          replication and transcription  148–49
          Inactivated vaccines  163, 222–23, 388. See also Vaccines and vaccination  viral RNA synthesis  149
          Inclusion body hepatitis (IBH)  272, 283, 293, 299–308  Infectious bursal disease (IBD)  211, 213, 217, 222–23, 274, 386
   408   409   410   411   412   413   414   415   416   417   418